Avalo Therapeutics, Inc. (AVTX) Strengthens Autoimmune Focus

Avalo Therapeutics, Inc. (AVTX) is a clinical-stage biopharmaceutical company focused on developing targeted therapies for autoimmune and rare diseases. Its pipeline includes novel drug candidates designed to address conditions with high unmet medical needs by modulating the immune system. Avalo’s growth is fueled by advancing clinical trials, partnerships that support drug development, and the growing demand for innovative treatments in rare and inflammatory diseases.

On the chart, a confirmation bar with rising volume highlights strong bullish sentiment. The price has entered the momentum zone by breaking above the .236 Fibonacci level. A trailing stop can be set just below that level using the Fibonacci snap tool, helping traders lock in profits while leaving room for further upside potential.